Bright Minds Biosciences's market cap is currently $253.40M. The company's EPS TTM is $-0.177; its P/E ratio is ―; Bright Minds Biosciences is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Sep 22	Sep 21	Sep 20	Sep 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -72.45K	C$ -6.04K	C$ 0.00	C$ 0.00	C$ 0.00
Operating Income	C$ -7.37M	C$ -14.74M	C$ -8.76M	C$ -469.36K	C$ -78.72K
EBITDA	C$ -7.28M	C$ -14.96M	C$ 0.00	C$ 0.00	C$ 0.00
Net Income	C$ -7.37M	C$ -15.19M	C$ -8.52M	C$ -485.94K	C$ -78.72K
Balance Sheet
Cash & Short-Term Investments	C$ 6.75M	C$ 11.63M	C$ 19.76M	C$ 799.93K	C$ 79.99K
Total Assets	C$ 6.88M	C$ 12.09M	C$ 20.04M	C$ 880.22K	C$ 163.97K
Total Debt	C$ 73.55K	C$ 139.91K	C$ 0.00	C$ 0.00	C$ 0.00
Net Debt	C$ -6.67M	C$ -11.49M	C$ -19.76M	C$ -799.93K	C$ -79.99K
Total Liabilities	C$ 280.86K	C$ 1.54M	C$ 638.57K	C$ 150.92K	C$ 36.71K
Stockholders' Equity	C$ 6.60M	C$ 10.54M	C$ 19.40M	C$ 729.29K	C$ 127.26K
Cash Flow
Free Cash Flow	C$ -7.02M	C$ -13.59M	C$ -7.32M	C$ -288.39K	C$ -42.01K
Operating Cash Flow	C$ -7.02M	C$ -13.59M	C$ -7.32M	C$ -288.39K	C$ -42.01K
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Financing Cash Flow	C$ 2.19M	C$ 5.20M	C$ 26.06M	C$ 1.01M	C$ 122.00K

Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

Income Statement >

Bright Minds Biosciences Debt to Assets

Balance Sheet >

Bright Minds Biosciences Cash Flow

Cash Flow >

Bright Minds Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing